Immix Biopharma IMMX
NASDAQ IMMX
$10.40 -0.14 (-1.28%)
At close: Sep 30, 2026 · 4:00 PM EDT

Immix Biopharma (IMMX) Notes Payables (2020 - 2022)

Updated

Immix Biopharma (IMMX) posted Notes Payables of $50,000 for Q1 2022, unchanged from the prior quarter.

Analysis

Immix Biopharma (IMMX) Notes Payables (2020 - 2022) Analysis & Trends

  • In prior years, Immix Biopharma's Notes Payables was $50,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Immix Biopharma 753.99 Mn 753.99 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 50,000.00
Dec 31, 2021 50,000.00
Dec 31, 2020 50,000.00
API Access

Immix Biopharma Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=IMMX&period=max&api_key=YOUR_API_KEY